ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 34757 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 34757; 2) Community: the network communities that were significantly associated with the response to NSC 34757; 3) Molecule: the relationships between components within communities and NSC 34757; 4) MDR: the compounds that were significantly associated with the NSC 34757.

NSC Compound Enrichment Correlation
NSC 710334 Null 0.0147237897640499 0.45887694
NSC 718728 5-[2-(2,5-Dimethoxyphenyl)ethynyl]-2-methoxyphenyl-N- [2-(4-fluorophenyl)ethyl]carboxamide 0.0147237897640499 0.54984547
NSC 722222 Null 0.0147237897640499 0.32919155
NSC 726768 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline 0.0147237897640499 0.16320228
NSC 756166 GSK312948A 0.0147237897640499 0.57002524
NSC 756251 GW559768X 0.0147237897640499 -0.15208795
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0147237897640499 0.59320797
NSC 79563 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine 0.0147237897640499 0.36006809
NSC 94600 Camptothecin 0.0147237897640499 0.0054016403
NSC 99733 Rheumygin 0.0147237897640499 0.018094823
Total:60  Current:23    [First] [Prev] [Next] [Last]